Guangdong VTR Bio-Tech (300381.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 6...
Finance and Economics APP News, Guangdong VTR Bio-Tech (300381.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.608 billion yuan, a year-on-year increase of 1.17%. The net income attributable to shareholders of the listed company was 42.7988 million yuan, a year-on-year increase of 245.33%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 14.0418 million yuan, a year-on-year increase of 8.11%.